Findings add to the understanding of centanafadine’s potential in the treatment of ADHD in adults Centanafadine is currently under Priority Review by the FDA, with a target action date of July 24, ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new post hoc, exploratory analyses from two identical Phase 3 clinical trials ...
PRINCETON, N.J. & TOKYO, May 28, 2026--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new post hoc, ...
Findings add to the understanding of centanafadine’s potential in the treatment of ADHD in adults Centanafadine is currently under Priority Review by the FDA, with a target action date of July 24, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results